486 related articles for article (PubMed ID: 27438521)
41. Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with Vogt-Koyanagi-Harada disease.
Urzua CA; Velasquez V; Sabat P; Berger O; Ramirez S; Goecke A; Vásquez DH; Gatica H; Guerrero J
Acta Ophthalmol; 2015 Sep; 93(6):e475-80. PubMed ID: 25565265
[TBL] [Abstract][Full Text] [Related]
42. Vogt-Koyanagi-Harada disease.
Damico FM; Kiss S; Young LH
Semin Ophthalmol; 2005; 20(3):183-90. PubMed ID: 16282153
[TBL] [Abstract][Full Text] [Related]
43. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients.
Yang P; Ren Y; Li B; Fang W; Meng Q; Kijlstra A
Ophthalmology; 2007 Mar; 114(3):606-14. PubMed ID: 17123618
[TBL] [Abstract][Full Text] [Related]
44. Predictive factors and adalimumab efficacy in managing chronic recurrence Vogt-Koyanagi-Harada disease.
Feng H; Chen W; Yang J; Kong H; Li H; He Y; Wang H
BMC Ophthalmol; 2024 Jun; 24(1):238. PubMed ID: 38849758
[TBL] [Abstract][Full Text] [Related]
45. Vogt-koyanagi-harada disease with onset in elderly patients aged 68 to 89 years.
Yamamoto Y; Fukushima A; Nishino K; Koura Y; Komatsu T; Ueno H
Jpn J Ophthalmol; 2007; 51(1):60-3. PubMed ID: 17295144
[TBL] [Abstract][Full Text] [Related]
46. [Clinical features, risk factors and progresses on treatment of recurrent Vogt-Koyanagi-Harada disease].
Jia SS; Zhao C; Liu XS; Zhang MF
Zhonghua Yan Ke Za Zhi; 2017 Apr; 53(4):317-320. PubMed ID: 28412807
[TBL] [Abstract][Full Text] [Related]
47. Acute phase clinical manifestations of patients with Vogt-Koyanagi-Harada disease in Southern China.
Zhang C; Wang Y; Chen Y; Zhou H; Hong Q; Yu X; Ng TK; Cen LP
BMC Ophthalmol; 2023 May; 23(1):199. PubMed ID: 37147563
[TBL] [Abstract][Full Text] [Related]
48. Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents.
Yang P; Ye Z; Du L; Zhou Q; Qi J; Liang L; Wu L; Wang C; Kijlstra A
Curr Eye Res; 2018 Feb; 43(2):254-261. PubMed ID: 29111815
[TBL] [Abstract][Full Text] [Related]
49. Complications and prognostic factors in Vogt-Koyanagi-Harada disease.
Read RW; Rechodouni A; Butani N; Johnston R; LaBree LD; Smith RE; Rao NA
Am J Ophthalmol; 2001 May; 131(5):599-606. PubMed ID: 11336934
[TBL] [Abstract][Full Text] [Related]
50. Prognostic factors for Vogt-Koyanagi-Harada disease.
Sheu SJ; Kou HK; Chen JF
J Chin Med Assoc; 2003 Mar; 66(3):148-54. PubMed ID: 12779034
[TBL] [Abstract][Full Text] [Related]
51. Vogt-Koyanagi-Harada syndrome and pregnancy.
Steahly LP
Ann Ophthalmol; 1990 Feb; 22(2):59-62. PubMed ID: 2316953
[TBL] [Abstract][Full Text] [Related]
52. COVID-19 Developed During Systemic Steroid Therapy for Vogt-Koyanagi-Harada Disease: A Case Report.
Niidome S; Usui Y; Tsubota K; Sugawara R; Goto H
Ocul Immunol Inflamm; 2023 Aug; 31(6):1305-1309. PubMed ID: 37084286
[TBL] [Abstract][Full Text] [Related]
53. Unilateral Ocular Manifestations of Vogt-Koyanagi-Harada Disease.
Tsui E; Bottini A; Ghadiali Q; Balaratnasingam C; Barbazetto I
Ocul Immunol Inflamm; 2018; 26(8):1297-1300. PubMed ID: 29020488
[TBL] [Abstract][Full Text] [Related]
54. [Two cases of Vogt-Koyanagi-Harada disease presenting shallow anterior chamber].
Takemoto D; Ijiri S; Shimizu M; Higashide T; Sugiyama K
Nippon Ganka Gakkai Zasshi; 2015 May; 119(5):354-62. PubMed ID: 26062392
[TBL] [Abstract][Full Text] [Related]
55. Vogt-Koyanagi-Harada Syndrome in a Canadian First Nations Population.
Kryshtalskyj MT; Roy M
Ocul Immunol Inflamm; 2022 May; 30(4):894-900. PubMed ID: 33621146
[TBL] [Abstract][Full Text] [Related]
56. The spectrum of Vogt-Koyanagi-Harada disease in South India.
Murthy SI; Moreker MR; Sangwan VS; Khanna RC; Tejwani S
Int Ophthalmol; 2007; 27(2-3):131-6. PubMed ID: 17318321
[TBL] [Abstract][Full Text] [Related]
57. Long-term efficacy of dexamethasone intravitreal implant in the treatment of Vogt-Koyanagi-Harada disease relapsing posterior uveitis.
Elhamaky TR
Indian J Ophthalmol; 2022 Jul; 70(7):2465-2470. PubMed ID: 35791135
[TBL] [Abstract][Full Text] [Related]
58. Outcomes of initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease occurred during pregnancy.
Alromaih AZ; Almater AI; Albloushi AF; Alkheraiji NF; Abu El-Asrar AM
Int Ophthalmol; 2023 Jan; 43(1):185-195. PubMed ID: 35945413
[TBL] [Abstract][Full Text] [Related]
59. Vogt-Koyanagi-Harada syndrome and ulcerative colitis.
Federman DG; Kravetz JD; Ruser CB; Judson PH; Kirsner RS
South Med J; 2004 Feb; 97(2):169-71. PubMed ID: 14982267
[TBL] [Abstract][Full Text] [Related]
60. Vogt-Koyanagi-Harada syndrome.
Moorthy RS; Inomata H; Rao NA
Surv Ophthalmol; 1995; 39(4):265-92. PubMed ID: 7725227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
